The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $469,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Michigan Technological University. The grant, titled "Dissecting Neural Circuit Mechanisms Underlying Pallidal Deep Brain Stimulation," will fund research to identify the neural elements and circuits necessary for the therapeutic effects of deep brain stimulation (DBS) of the globus...
This Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the basal ganglia network neurophysiology of depression in Parkinson's disease (PD). The objective is to identify basal ganglia neural activity associated with depression in PD, determine the brain regions and networks involved, and determine brain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $176,079 to Vanderbilt University Medical Center (VUMC) to characterize the neurophysiology of reward signaling in the subthalamic nucleus and dorsolateral prefrontal cortex, and determine how acute and chronic deep brain stimulation of the subthalamic nucleus impacts reward...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support the development of a closed-loop deep brain stimulation (DBS) computational framework. The $146,500 award, effective from July 2, 2024 to June 30, 2028, aims to create novel open-loop and closed-loop multi-input multi-output (MIMO) DBS techniques to provide...
The federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research aimed at developing a highly personalized approach to thalamic neuromodulation for treating drug-resistant epilepsy. The $256,500 award, spanning from January 1, 2025 to December 31, 2029, will enable the principal investigator at Mayo Clinic to: 1) map...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) is funding research to deepen the understanding of how deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) suppresses seizures in patients with drug-resistant epilepsy. The total award amount is $1,569,716.00 over the project period from August 20, 2024 to June 30,...
This Project Grant award of $527,037 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research at New York University (NYU) to investigate how the basal ganglia and motor thalamus in the human brain integrate cognitive and motor processes, with the goal of developing brain stimulation strategies to treat movement and...
This federal Project Grant award of $163,184, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by New York University (NYU) to investigate the relationship between speech planning deficits and neurological disorders such as Parkinson's disease (PD). The research aims to dissect the function of the caudal middle frontal gyrus (CMFG), a...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $465,500.00 to Trustees of Boston University to conduct research on "Close-Loop Deep Brain Optoacoustic Stimulation at Sub-Millimeter Precision". The award has a start date of July 5, 2025 and an ultimate completion date of June 30, 2027. The research aims to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $679,899 to The University of Texas Southwestern Medical Center to conduct research on using positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) as a potential biomarker for essential tremor, a common neurodegenerative disease. The 5-year...